Cellebrite director discloses 20,974 shares stake
Cellebrite DI Ltd. director Troy Richardson filed an initial ownership report showing he holds 20,974 Ordinary Shares.
Rhea-AI Filing Summary
Cellebrite DI Ltd. director Troy Richardson filed an initial ownership report showing he holds 20,974 Ordinary Shares. This is a Form 3 filing, which establishes his starting stake as a company insider rather than reporting any new trade.
The position includes 10,601 Ordinary Shares represented by restricted share units granted on September 17, 2025, which are scheduled to vest on September 17, 2026. Each restricted unit converts into one Ordinary Share when it settles, so part of his reported holdings is still subject to future vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary shares, par value NIS 0.00001 ("Ordinary Shares") | -- | -- | -- |
Footnotes (1)
- F1. Includes 10,601 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 17, 2025 and vest on September 17, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Troy Richardson’s Form 3 filing for Cellebrite (CLBT) show?
Why is Troy Richardson’s Cellebrite (CLBT) Form 3 important for investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.